Joseph H. Dawson - 17 Nov 2025 Form 4 Insider Report for ROCKWELL MEDICAL, INC. (RMTI)

Role
Director
Signature
/s/ Megan Timmins, Attorney-in-Fact for Joseph Dawson
Issuer symbol
RMTI
Transactions as of
17 Nov 2025
Net transactions value
$0
Form type
4
Filing time
20 Nov 2025, 19:37:17 UTC
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Dawson Joseph H Director C/O ROCKWELL MEDICAL, INC., 30142 WIXOM ROAD, WIXOM /s/ Megan Timmins, Attorney-in-Fact for Joseph Dawson 20 Nov 2025 0002097560

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RMTI Common Stock Award $0 +25,000 $0.000000 25,000 17 Nov 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RMTI Stock Option (Right to Buy) Award $0 +25,000 $0.000000 25,000 17 Nov 2025 Common Stock 25,000 $0.8700 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units vest on November 17, 2026, subject to the Reporting Person's continued service to the Issuer.
F2 Stock options vest on November 17, 2026, subject to the Reporting Person's continued service to the Issuer.

Remarks:

This Form 4 is being filed late due to administrative delays in obtaining the Reporting Person's EDGAR codes.